Gilead Sciences Inc. (GILD) Fundamentals

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology.
SHARE INFORMATION
Market Cap$ 79,588,829,519
Shares Outstanding1,253,367,394
Float1,258,754,556
Percent Float100.43%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.84
Latest Fiscal Revenue$ 27,305,000,000
Latest Fiscal EPS$ 4.93
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 6.04
Dividend (5 Years)$ 7.97
Ex Dividend Date2022-09-14
Dividend Rate$ 2.92
Dividend Yield4.6%
Payment CashCash
HOLDERS
Institutions3,414
Institutional Holdings Date2021-03-31
Institutional Bought Previous 3 Months90,602,390
Institutional Holdings Percent82.1%
Institutional Sold Previous 3 Months167,012,326
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months21,119
Insider Holdings Percent0.6
Insider Sold Previous 3 Months30,239
Insider Shares Owned7,999,222
TRADING INFO
52 Week High$ 74.12
52 Week Low$ 57.17
52 Week High Change$ -7.26
21 Day Moving Average$ 63.8577
21 Day Extended Moving Average$ 64.5323
50 Day Moving Average$ 62.5286
50 Day Extended Moving Average$ 63.6655
200 Day Moving Average$ 62.2863
200 Day Extended Moving Average$ 63.7575
10 Day Average Volume9,451,033
20 Day Average Volume7,838,090
30 Day Average Volume7,353,381
50 Day Average Volume6,921,410
Alpha-0.002124
Beta0.3156
Standard Deviation0.067675
R20.055362
7 Day Price Change$ -1.68
7 Day Percent Change-2.58%
21 Day Price Change$ 0.74175
21 Day Percent Change1.18%
30 Day Price Change$ -1.11
30 Day Percent Change-1.71%
Month to Date Price Change$ 0.7418
Month to Date Percent Change1.18%
Quarter to Date Price Change$ 2.38
Quarter to Date Percent Change3.9%
180 Day Price Change$ 5.24
180 Day Percent Change8.99%
200 Day Price Change$ 3.85
200 Day Percent Change6.45%
Year to Date Price Change$ -6.52
Year to Date Percent Change-9.31%

Gilead Sciences Inc. (GILD) Key Ratios

PROFITABILITY
EBIT Margin23.7%
EBITDA Margin31.3%
Pre-Tax Profit Margin29.0%
Profit Margin Count14.98%
Gross Margin75.6%
Profit Margin TOT14.98%
INCOME STATEMENTS
Revenue$ 27,515,000,000
Revenue Per Share$ 21.9529
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-4.50
Total Debt To Equity1.30
Int Coverage6.70
Current Ratio1.40
Leverage Ratio3.20
Quick Ratio1.10
Long Term Debt To Capital0.55
VALUATION MEASURES
PE Ratio19.70
Enterprise Value$ 101,495,466,304
Price to Sales2.8926
Price to Free Cash17.90
PE High Last 5 Years823.60
Price To Book4.00
Price To Cash Flow8.10
PE Low Last 5 Years6.40
Price to Tangible Book-4.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.30
Invoice Turnover4.40
Assets Turnover0.40
Return Assets6.73
Return on Equity21.98
Return on Capital10.08

Gilead Sciences Inc. (GILD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEODaniel O'Day
Emplyoees11800
Last AuditUQ
CIK0000882095
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address333 Lakeside Drive
Foster City, CA 94404
Websitehttps://www.gilead.com
Facsimile+1 650 578-9264
Telephone+1 650 574-3000
Emailinvestor_relations@gilead.com


Your Recent History
NASDAQ
GILD
Gilead Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.